Finance

Lists
PMVP:NASDAQ
PMV Pharmaceuticals Inc
1,26 US$
-1,18%
(-0,015) 1D
6 ნოე, 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMVP...
Open
1,28 US$
High
1,29 US$
Low
1,24 US$
Mkt. cap
95,52 მლნ.
Avg. vol.
714,77 ათ.
Volume
194,32 ათ.
52-wk high
1,91 US$
52-wk low
1,02 US$
EPS
-1,41 US$
Beta
1,52
Shares outstanding
75,51 მლნ.
No. of employees
54
Open
1,28 US$
High
1,29 US$
Low
1,24 US$
Mkt. cap
95,52 მლნ.
Avg. vol.
714,77 ათ.
Volume
194,32 ათ.
52-wk high
1,91 US$
52-wk low
1,02 US$
EPS
-1,41 US$
Beta
1,52
Shares outstanding
75,51 მლნ.
No. of employees
54
News stories
From web sources and news partners
About PMV Pharmaceuticals Inc
CEO-
Employees54
Founded2013
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 4 analysts giving stock ratings to PMVP in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for PMVP in the last 3 months.
Highest
Current 1,26 US$
5,00 US$ (+296,83%)
Average
4,00 US$ (+217,46%)
Lowest
3,00 US$ (+138,10%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
5,00 US$
+296,8%
09/08/2026
Unknown Analyst
Craig-Hallum
Buy
Reiterated
4,00 US$
+217,5%
09/01/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
4,00 US$
+217,5%
09/01/2026
Jay Olson
Oppenheimer
Buy
Reiterated
5,00 US$
+296,8%
09/01/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
5,00 US$
+296,8%
09/01/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
3,00 US$
+138,1%
08/17/2026
Rick Bienkowski
Ladenburg Thalmann & Co.
Buy
Reiterated
3,00 US$
+138,1%
08/17/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
05/12/2026
Albert Lowe
Craig-Hallum
Buy
Maintained
4,00 US$
+217,5%
11/13/2025
Next call 5 დღეში
პარ, 13 ნოე, 16:30
Fiscal period
Q3 2026
- / -0,33 US$
Revenue / Est. (USD)
- / 0,00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
18,21 მლნ.
15,83 მლნ.
15,33 მლნ.
14,68 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,31 მლნ.
3,42 მლნ.
3,69 მლნ.
4,20 მლნ.
Operating expense
22,52 მლნ.
19,24 მლნ.
19,02 მლნ.
18,88 მლნ.
Total operating expenses
22,52 მლნ.
19,24 მლნ.
19,02 მლნ.
18,88 მლნ.
Operating income
-22,52 მლნ.
-19,24 მლნ.
-19,02 მლნ.
-18,88 მლნ.
Other non operating income
-23,00 ათ.
-1,00 ათ.
1,00 ათ.
10,00 ათ.
EBT including unusual items
-21,06 მლნ.
-18,01 მლნ.
-18,04 მლნ.
-18,08 მლნ.
EBT excluding unusual items
-21,06 მლნ.
-18,01 მლნ.
-18,04 მლნ.
-18,08 მლნ.
Income tax expense
-6,00 ათ.
26,00 ათ.
-
3,00 ათ.
Effective tax rate
0,03%
-0,14%
-
-0,02%
Other operating expenses
-
-
-
-
Net income
-21,06 მლნ.
-18,04 მლნ.
-18,04 მლნ.
-18,09 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,40
-0,34
-0,34
-0,34
Interest and investment income
1,48 მლნ.
1,23 მლნ.
980,00 ათ.
788,00 ათ.
Interest expense
-
-
-
-
Net interest expenses
1,48 მლნ.
1,23 მლნ.
980,00 ათ.
788,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-22,49 მლნ.
-19,21 მლნ.
-18,98 მლნ.
-18,86 მლნ.
Gain or loss from assets sale
-1,00 ათ.
-
-
25,00 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები